The p53 circuit board

被引:81
作者
Sullivan, Kelly D.
Gallant-Behm, Corrie L.
Henry, Ryan E.
Fraikin, Jean-Luc
Espinosa, Joaquin M. [1 ]
机构
[1] Univ Colorado Boulder, Howard Hughes Med Inst, Boulder, CO 80309 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER | 2012年 / 1825卷 / 02期
关键词
Gene network; PUMA; p21; Apoptosis; Cell cycle arrest; Personalized medicine; UBIQUITIN LIGASE ITCH; MESSENGER-RNA STABILIZATION; CYCLIN-DEPENDENT KINASES; BH3-ONLY PROTEIN NOXA; DNA-DAMAGE; GENE-EXPRESSION; MUTANT P53; WILD-TYPE; REPRESSES TRANSCRIPTION; ABERRANT METHYLATION;
D O I
10.1016/j.bbcan.2012.01.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The p53 tumor suppressor is embedded in a large gene network controlling diverse cellular and organismal phenotypes. Multiple signaling pathways converge onto p53 activation, mostly by relieving the inhibitory effects of its repressors, MDM2 and MDM4. In turn, signals originating from increased p53 activity diverge into distinct effector pathways to deliver a specific cellular response to the activating stimuli. Much attention has been devoted to dissecting how the various input pathways trigger p53 activation and how the activity of the p53 protein itself can be modulated by a plethora of co-factors and post-translational modifications. In this review we will focus instead on the multiple configurations of the effector pathways. We will discuss how p53-generated signals are transmitted, amplified, resisted and eventually integrated by downstream gene circuits operating at the transcriptional, post-transcriptional and post-translational levels. We will also discuss how context-dependent variations in these gene circuits define the cellular response to p53 activation and how they may impact the clinical efficacy of p53-based targeted therapies. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:229 / 244
页数:16
相关论文
共 215 条
[1]   APC/CCdc20 controls the ubiquitin-mediated degradation of p21 in prometaphase [J].
Amador, Virginia ;
Ge, Sheng ;
Santamaria, Patricia G. ;
Guardavaccaro, Daniele ;
Pagano, Michele .
MOLECULAR CELL, 2007, 27 (03) :462-473
[2]   Myc and PI3K/AKT signaling cooperatively repress FOXO3a-dependent PUMA and GADD45a gene expression [J].
Amente, Stefano ;
Zhang, Jiyuan ;
Lavadera, Miriam Lubrano ;
Lania, Luigi ;
Avvedimento, Enrico Vittorio ;
Majello, Barbara .
NUCLEIC ACIDS RESEARCH, 2011, 39 (22) :9498-9507
[3]   BRCA1 is a selective co-activator of 14-3-3σ gene transcription in mouse embryonic stem cells [J].
Aprelikova, O ;
Pace, AJ ;
Fang, B ;
Koller, BH ;
Liu, ET .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (28) :25647-25650
[4]  
Attardi LD, 2000, GENE DEV, V14, P704
[5]   SUPPRESSION OF HUMAN COLORECTAL-CARCINOMA CELL-GROWTH BY WILD-TYPE-P53 [J].
BAKER, SJ ;
MARKOWITZ, S ;
FEARON, ER ;
WILLSON, JKV ;
VOGELSTEIN, B .
SCIENCE, 1990, 249 (4971) :912-915
[6]  
BAKER SJ, 1990, CANCER RES, V50, P7717
[7]   CHROMOSOME-17 DELETIONS AND P53 GENE-MUTATIONS IN COLORECTAL CARCINOMAS [J].
BAKER, SJ ;
FEARON, ER ;
NIGRO, JM ;
HAMILTON, SR ;
PREISINGER, AC ;
JESSUP, JM ;
VANTUINEN, P ;
LEDBETTER, DH ;
BARKER, DF ;
NAKAMURA, Y ;
WHITE, R ;
VOGELSTEIN, B .
SCIENCE, 1989, 244 (4901) :217-221
[8]   A role for Chk1 in blocking transcriptional elongation of p21 RNA during the S-phase checkpoint [J].
Beckerman, Rachel ;
Donner, Aaron J. ;
Mattia, Melissa ;
Peart, Melissa J. ;
Manley, James L. ;
Espinosa, Joaquin M. ;
Prives, Carol .
GENES & DEVELOPMENT, 2009, 23 (11) :1364-1377
[9]   It's Diagnostics, Stupid [J].
Bernards, Rene .
CELL, 2010, 141 (01) :13-17
[10]   Ubiquitin-dependent degradation of p73 is inhibited by PML [J].
Bernassola, F ;
Salomoni, P ;
Oberst, A ;
Di Como, CJ ;
Pagano, M ;
Melino, G ;
Pandolfi, PP .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (11) :1545-1557